Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001209191-23-011457 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | BBIO | SCHELLER RICHARD H | Dir | M - OptEx | — | +3,196 | 55.1K | +6% | — |
| D | 2023-02-21 | 2023-02-16 | BBIO | SCHELLER RICHARD H | Dir | F - Tax | $12.64 | -1,304 | 53.8K | -2% | -$16.5K |
| D | 2023-02-21 | 2023-02-16 | BBIO | SCHELLER RICHARD H | Dir | M - OptEx | $0.00 | -3,196 | 12.8K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | M | A | 3,196 | — | 55,126 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2023-02-16 | F | D | 1,304 | $12.64 | 53,822 | D | — | — | (F2) Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs. |
| 3 | Derivative | Restricted Stock Units | 2023-02-16 | M | D | 3,196 | $0.00 | 12,783 | D | — · — to — | 3,196 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. |